PRWeb.com Press Release Feed - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/90550.xml PRWeb.com Press Release Feed - Press Releases en xml@emediawire.com xml@emediawire.com 30 TABMMI Heart Failure Stem Cell Clinical Trial Results Presented; Improvements Sustained at Three Year Follow-up http://www.prweb.com/releases/2009/03/prweb2224294.htm BioCardia announces scientific presentation of clinical results at the 2009 Cardiac Research Technologies meeting in Washington DC. The presentation entitled: "Three Year Follow-up in an Open-Label, Pilot Study of Transendocardial Autologous Bone Marrow in Chronic Myocardial Infarction (TABMMI) using a Helical Needle Catheter" presented data by investigator Dr. Luis de la Fuente. (PRWeb Mar 12, 2009)

Read the full story at http://www.prweb.com/releases/2009/03/prweb2224294.htm

]]> Thu, 12 Mar 2009 07:00:00 GMT http://www.prweb.com/releases/2009/03/prweb2224294.htm BioCardia and the University of Miami Receive FDA Clearance to Initiate Co-Sponsored Heart Failure Stem Cell Clinical Trial Comparing Two Cell Populations http://www.prweb.com/releases/2008/04/prweb904454.htm BioCardia, Inc., a regenerative medicine company, and the University of Miami today announced that the United States Food and Drug Administration approved a clinical investigation of two adult stem cell populations in the setting of heart failure. (PRWeb Apr 30, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb904454.htm

]]> Wed, 30 Apr 2008 07:00:00 GMT http://www.prweb.com/releases/2008/04/prweb904454.htm BioCardia Completes $7.4 Million Private Equity Financing Following Successful Phase I Clinical Trial Enrollment and Two Year Followup Data http://www.prweb.com/releases/2008/04/prweb894564.htm BioCardia, Inc., a regenerative medicine company, today announced the completion of a new round of financing, raising $7.4 million from existing and new investors. (PRWeb Apr 27, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb894564.htm

]]> Sun, 27 Apr 2008 07:00:00 GMT http://www.prweb.com/releases/2008/04/prweb894564.htm BioCardia Announces Completion of Enrollment of TABMMI Cardiac Stem Cell Trial http://www.prweb.com/releases/2008/03/prweb815494.htm BioCardia announces completion of enrollment in the Transendocardial Autologous Bone Marrow in Myocardial Infarction (TABMMI) trial with perfect procedural safety results in all twenty patients treated. The trial led by principle investigator Dr. Luis de la Fuente presented two year follow-up on the first ten patients at the CRT meeting in Washington in February supporting long term safety and the therapeutic benefit of this approach. (PRWeb Mar 31, 2008)

Read the full story at http://www.prweb.com/releases/2008/03/prweb815494.htm

]]> Mon, 31 Mar 2008 07:00:00 GMT http://www.prweb.com/releases/2008/03/prweb815494.htm BioCardia, South San Francisco, CA and Symphony Medical, Eden Prairie, MN announce License, Development, and Commercialization Agreement http://www.prweb.com/releases/2005/01/prweb195465.htm BioCardia, Inc. and Symphony Medical, Inc. announce a mutually exclusive agreement for development and commercialization of a combination product that combines Symphony Medical's biotherapeutic technology and BioCardia device delivery technology for the treatment of cardiac conduction disorders. (PRWeb Jan 9, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb195465.htm

]]> Sun, 09 Jan 2005 08:00:00 GMT http://www.prweb.com/releases/2005/01/prweb195465.htm